Descriptive, prognostic study of SARS-CoV-2 coronavirus infection in Martinique, conducted in a hospital cohort of patients with probable or confirmed COVID-19 infection FRESH-PEF73828-en Valentine CAMPANA Descriptive, prognostic study of SARS-CoV-2 coronavirus infection in Martinique, conducted in a hospital cohort of patients with probable or confirmed COVID-19 infection EPIC FRESH-PEF73828-en 73828 FRESH-PEF73828 Cyrille CHABARTIER André CABIE CENTRE HOSPITALIER UNIVERSITAIRE DE LA MARTINIQUE Epidemiology France Portal (PEF) CENTRE HOSPITALIER UNIVERSITAIRE DE LA MARTINIQUE null André;CABIE severe forms demographic virological immunological clinical predictive factors biological Infectious disease medicine Certain other viral diseases COVID-19 Identify the demographic, clinical, biological, virological and immunological factors associated with, or predictive of the onset of a severe form of COVID-19 in a cohort of children and adults managed in a hospital setting at Martinique University Hospital. null France Martinique Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Inclusion criterion: Patient hospitalised in a COVID-specific treatment unit, including intensive care, for possible or confirmed SARS-CoV-2 infection (PCR+ and/or CT scan consistent with infection) at Martinique University Hospital. Refusal to take part, by the patient or their legal representativecriteria: patient with confirmed diagnosis of infection with a pathogen other than SARS-CoV-2, and no likelihood of co-infection with SARS-CoV-2 Clinical data Biological data Health event/morbidity Health event/mortality Others Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Physical/biological measurements (blood pressure, weight, biochemistry, imaging, etc.) Converting or copying information into a structured record Observational Study Observational Study Approximately 150 patients for the first wave, second wave ongoing Unknown Restricted access Access on specific project only